GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Treasury Stock

Roquefort Therapeutics (LSE:ROQ) Treasury Stock : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Roquefort Therapeutics's treasury stock for the quarter that ended in Dec. 2023 was £0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Roquefort Therapeutics Treasury Stock Historical Data

The historical data trend for Roquefort Therapeutics's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Treasury Stock Chart

Roquefort Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Treasury Stock
- - -

Roquefort Therapeutics Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23
Treasury Stock - - - - -

Roquefort Therapeutics Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Treasury Stock
Comparable Companies
AQSE:PBX LSE:BSFA LSE:BVX LSE:IMM LSE:OCTP LSE:CIZ LSE:IXI LSE:APTA LSE:ONC LSE:VAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ROQAF:USA
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Website
https://www.roquefortplc.com
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines